The effect of diabetes mellitus on apoptosis in hippocampus: Cellular and molecular aspects

International Journal of Preventive Medicine

Volumn 2016-March, Issue , 2016, Pages

  Sadeghi, Akram ^a   Hami, Javad ^b   Razavi, Shahnaz ^a   Esfandiary, Ebrahim ^a   Hejazi, Zahra ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Apoptosis; Central nervous system complication; Diabetes mellitus; Hippocampus

Indexed keywords

ACETYLCHOLINESTERASE; ALPHA TOCOTRIENOL; BUTYLPHTHALIDE; C PEPTIDE; CASPASE; CASPASE 3; CHINESE DRUG; FISH OIL; GRAPE SEED EXTRACT; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; INTERLEUKIN 1BETA; MESSENGER RNA; NAOKANGERHAO DECOCTION; SERICIN; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; ATTENTION; BAX GENE; BEHAVIOR DISORDER; CASPASE 3 GENE; CELL DEATH; CELL FUNCTION; CELL PROLIFERATION; COGNITIVE DEFECT; COMPREHENSION; DENTATE GYRUS; DIABETIC ENCEPHALOPATHY; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; EXERCISE; EXPERIMENTAL DIABETES MELLITUS; EXPERIMENTAL STUDY; GENE EXPRESSION; GRANULAR CELL; HIPPOCAMPUS; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LEARNING DISORDER; MEMORY; MOLECULAR BIOLOGY; MOTOR PERFORMANCE; MULTIINFARCT DEMENTIA; NEUROPSYCHOLOGY; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN EXPRESSION; REGULATOR GENE; REVIEW; RODENT; SHORT TERM MEMORY; SIGNAL TRANSDUCTION; SYSTEMATIC REVIEW; TUNEL ASSAY;

EID: 84963704413     PISSN: 20087802     EISSN: 20088213     Source Type: Journal    
DOI: 10.4103/2008-7802.178531     Document Type: Review

References (96)

1. Cosson E. Diagnostic criteria for gestational diabetes mellitus. Diabetes Metab 2010;36(6 Pt 2):538-48.
2. Khan MN, Khan FA, Sultana S, Dilawar M, Ijaz A, Khan MJ, et al. Impact of new diagnostic criteria of diabetes mellitus. J Coll Physicians Surg Pak 2007;17:327-30.
3. Dagogo-Jack S, Santiago JV. Pathophysiology of type 2 diabetes and modes of action of therapeutic interventions. Arch Intern Med 1997;157:1802-17.
4. Yi SS. Effects of exercise on brain functions in diabetic animal models. World J Diabetes 2015;6:583-97.
5. Tran L, Zielinski A, Roach AH, Jende JA, Householder AM, Cole EE, et al. Pharmacologic treatment of type 2 diabetes: Oral medications. Ann Pharmacother 2015;49:540-56.
6. Conde Barreiro S, Rodríguez Rigual M, Bueno Lozano G, López Siguero JP, González Pelegrín B, Rodrigo Val MP, et al. Epidemiology of type 1 diabetes mellitus in children in Spain. An Pediatr (Barc) 2014;81:189.e1-12.
7. Huber CA, Schwenkglenks M, Rapold R, Reich O. Epidemiology and costs of diabetes mellitus in Switzerland: An analysis of health care claims data, 2006 and 2011. BMC Endocr Disord 2014;14:44.
8. Harris MI. Epidemiology of diabetes mellitus among the elderly in the United States. Clin Geriatr Med 1990;6:703-19.
9. Harris MI, Hadden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in U.S. population aged 20-74 yr. Diabetes 1987;36:523-34.
10. Cukierman-Yaffe T. Diabetes, dysglycemia and cognitive dysfunction. Diabetes Metab Res Rev 2014;30:341-5.
11. McCrimmon RJ, Ryan CM, Frier BM. Diabetes and cognitive dysfunction. Lancet 2012;379:2291-9.
12. Reijmer YD, van den Berg E, Ruis C, Kappelle LJ, Biessels GJ. Cognitive dysfunction in patients with type 2 diabetes. Diabetes Metab Res Rev 2010;26:507-19.
13. Alvarez EO, Beauquis J, Revsin Y, Banzan AM, Roig P, De Nicola AF, et al. Cognitive dysfunction and hippocampal changes in experimental type 1 diabetes. Behav Brain Res 2009;198:224-30.
14. Kodl CT, Seaquist ER. Cognitive dysfunction and diabetes mellitus. Endocr Rev 2008;29:494-511.
15. Matanovic D, Popovic S, Parapid B, Dubljanin E, Stanisavljevic D, Ille T. Evaluation of neurophysiological parameters and good metabolic control in patients with type 1 diabetes mellitus. Srp Arh Celok Lek 2012;140:285-9.
16. Zhou X, Zhang J, Chen Y, Ma T, Wang Y, Wang J, et al. Aggravated cognitive and brain functional impairment in mild cognitive impairment patients with type 2 diabetes: A resting-state functional MRI study. J Alzheimers Dis 2014;41:925-35.
17. van Harten B, Oosterman JM, Potter van Loon BJ, Scheltens P, Weinstein HC. Brain lesions on MRI in elderly patients with type 2 diabetes mellitus. Eur Neurol 2007;57:70-4.
18. Meece J. Diabetes mellitus: Pathophysiology and complications. Int J Pharm Compd 2003;7:17-20.
19. Mooradian AD. Pathophysiology of central nervous system complications in diabetes mellitus. Clin Neurosci 1997;4:322-6.
20. Pirart J. Diabetes mellitus and its degenerative complications: A prospective study of 4, 400 patients observed between 1947 and 1973 (3rd and last part) (author's transl). Diabete Metab 1977;3:245-56.
21. Gispen WH, Biessels GJ. Cognition and synaptic plasticity in diabetes mellitus. Trends Neurosci 2000;23:542-9.
22. Chuiko MR, Bodykhov MK, Skvortsova VI. Characteristics and peculiarities of the course of encephalopathy in diabetes mellitus. Zh Nevrol Psikhiatr Im S S Korsakova 2010;110(5 Pt 1):4-8.
23. Brands AM, Henselmans JM, de Haan EH, Biessels GJ. Diabetic encephalopathy: An underexposed complication of diabetes mellitus. Ned Tijdschr Geneeskd 2003;147:11-4.
24. Brands AM, Biessels GJ, de Haan EH, Kappelle LJ, Kessels RP. The effects of type 1 diabetes on cognitive performance: A meta-analysis. Diabetes Care 2005;28:726-35.
25. Strachan MW, Deary IJ, Ewing FM, Frier BM. Is type II diabetes associated with an increased risk of cognitive dysfunction? A critical review of published studies. Diabetes Care 1997;20:438-45.
26. Ma L, Wang J, Li Y. Insulin resistance and cognitive dysfunction. Clin Chim Acta 2015;444:18-23.
27. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group, Jacobson AM, Musen G, Ryan CM, Silvers N, Cleary P, et al. Long-term effect of diabetes and its treatment on cognitive function. N Engl J Med 2007;356:1842-52.
28. Bryan RN, Bilello M, Davatzikos C, Lazar RM, Murray A, Horowitz K, et al. Effect of diabetes on brain structure: The action to control cardiovascular risk in diabetes MR imaging baseline data. Radiology 2014;272:210-6.
29. Ferguson SC, Blane A, Perros P, McCrimmon RJ, Best JJ, Wardlaw J, et al. Cognitive ability and brain structure in type 1 diabetes: Relation to microangiopathy and preceding severe hypoglycemia. Diabetes 2003;52:149-56.
30. Musen G, Lyoo IK, Sparks CR, Weinger K, Hwang J, Ryan CM, et al. Effects of type 1 diabetes on gray matter density as measured by voxel-based morphometry. Diabetes 2006;55:326-33.
31. Sima AA, Kamiya H, Li ZG. Insulin, C-peptide, hyperglycemia, and central nervous system complications in diabetes. Eur J Pharmacol 2004;490:187-97.
32. Huber JD, VanGilder RL, Houser KA. Streptozotocin-induced diabetes progressively increases blood-brain barrier permeability in specific brain regions in rats. Am J Physiol Heart Circ Physiol 2006;291:H2660-8.
33. Sridhar GR, Lakshmi G, Nagamani G. Emerging links between type 2 diabetes and Alzheimer's disease. World J Diabetes 2015;6:744-51.
34. Yonguc GN, Dodurga Y, Adiguzel E, Gundogdu G, Kucukatay V, Ozbal S, et al. Grape seed extract has superior beneficial effects than Vitamin E on oxidative stress and apoptosis in the hippocampus of streptozotocin induced diabetic rats. Gene 2015;555:119-26.
35. Ghasemi R, Zarifkar A, Rastegar K, Maghsoudi N, Moosavi M. Insulin protects against Aß-induced spatial memory impairment, hippocampal apoptosis and MAPKs signaling disruption. Neuropharmacology 2014;85:113-20.
36. Sun LJ, Hou XH, Xue SH, Yan F, Dai YJ, Zhao CH, et al. Fish oil modulates glycogen synthase kinase-3 signaling pathway in diabetes-induced hippocampal neurons apoptosis. Brain Res 2014;1574:37-49.
37. Jafari Anarkooli I, Barzegar Ganji H, Pourheidar M. The protective effects of insulin and natural honey against hippocampal cell death in streptozotocininduced diabetic rats. J Diabetes Res 2014;2014:491571.
38. Alipour M, Salehi I, Ghadiri Soufi F. Effect of exercise on diabetes-induced oxidative stress in the rat hippocampus. Iran Red Crescent Med J 2012;14:222-8.
39. Zhao CH, Liu HQ, Cao R, Ji AL, Zhang L, Wang F, et al. Effects of dietary fish oil on learning function and apoptosis of hippocampal pyramidal neurons in streptozotocin-diabetic rats. Brain Res 2012;1457:33-43.
40. Chen Z, He Y, Song C, Dong Z, Su Z, Xue J. Sericin can reduce hippocampal neuronal apoptosis by activating the Akt signal transduction pathway in a rat model of diabetes mellitus. Neural Regen Res 2012;7:197-201.
41. Chen Y, Li L, Li Z, Huang X, Zhang L, Chen W. Effects of naokang erhao decoction on cognitive ability and hippocampal apoptosis-related proteins in diabetic rats. Zhongguo Zhong Yao Za Zhi 2011;36:1519-23.
42. Zhang T, Jia W, Sun X. 3-n-butylphthalide (NBP) reduces apoptosis and enhances vascular endothelial growth factor (VEGF) up-regulation in diabetic rats. Neurol Res 2010;32:390-6.
43. Jafari Anarkooli I, Sankian M, Ahmadpour S, Varasteh AR, Haghir H. Evaluation of Bcl-2 family gene expression and caspase-3 activity in hippocampus STZinduced diabetic rats. Exp Diabetes Res 2008;2008:638467.
44. Kuhad A, Bishnoi M, Tiwari V, Chopra K. Suppression of NF-kappabeta signaling pathway by tocotrienol can prevent diabetes associated cognitive deficits. Pharmacol Biochem Behav 2009;92:251-9.
45. Cosar M, Songur A, Sahin O, Uz E, Yilmaz R, Yagmurca M, et al. The neuroprotective effect of fish n-3 fatty acids in the hippocampus of diabetic rats. Nutr Neurosci 2008;11:161-6.
46. Sima AA, Li ZG. The effect of C-peptide on cognitive dysfunction and hippocampal apoptosis in type 1 diabetic rats. Diabetes 2005;54:1497-505.
47. Li ZG, Zhang W, Sima AA. C-peptide prevents hippocampal apoptosis in type 1 diabetes. Int J Exp Diabetes Res 2002;3:241-5.
48. Biessels GJ, Kamal A, Ramakers GM, Urban IJ, Spruijt BM, Erkelens DW, et al. Place learning and hippocampal synaptic plasticity in streptozotocin-induced diabetic rats. Diabetes 1996;45:1259-66.
49. Popoviç M, Biessels GJ, Isaacson RL, Gispen WH. Learning and memory in streptozotocin-induced diabetic rats in a novel spatial/object discrimination task. Behav Brain Res 2001;122:201-7.
50. Flood JF, Mooradian AD, Morley JE. Characteristics of learning and memory in streptozocin-induced diabetic mice. Diabetes 1990;39:1391-8.
51. Chen L, Gong S, Shan LD, Xu WP, Zhang YJ, Guo SY, et al. Effects of exercise on neurogenesis in the dentate gyrus and ability of learning and memory after hippocampus lesion in adult rats. Neurosci Bull 2006;22:1-6.
52. Kamal A, Biessels GJ, Duis SE, Gispen WH. Learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: Interaction of diabetes and ageing. Diabetologia 2000;43:500-6.
53. Biessels GJ, Kamal A, Urban IJ, Spruijt BM, Erkelens DW, Gispen WH. Water maze learning and hippocampal synaptic plasticity in streptozotocin-diabetic rats: Effects of insulin treatment. Brain Res 1998;800:125-35.
54. Pamidi N, Satheesha Nayak BN. Effect of streptozotocin induced diabetes on rat hippocampus. Bratisl Lek Listy 2012;113:583-8.
55. Foghi K, Ahmadpour S. Diabetes mellitus type1 and neuronal degeneration in ventral and dorsal hippocampus. Iran J Pathol 2014;9:33.
56. Witter M, Amaral DG. The Rat Nervous System. California, USA: Elsevier Academic; 2004.
57. Squire LR. Memory and the hippocampus: A synthesis from findings with rats, monkeys, and humans. Psychol Rev 1992;99:195-231.
58. Lewis S. Learning and memory: Hippocampus plays multiple choice. Nat Rev Neurosci 2012;13:600.
59. Turgut YB, Turgut M. A mysterious term hippocampus involved in learning and memory. Childs Nerv Syst 2011;27:2023-5.
60. Jarrard LE. On the role of the hippocampus in learning and memory in the rat. Behav Neural Biol 1993;60:9-26.
61. Kang JO, Kim SK, Hong SE, Lee TH, Kim CJ. Low dose radiation overcomes diabetes-induced suppression of hippocampal neuronal cell proliferation in rats. J Korean Med Sci 2006;21:500-5.
62. Kitamura T, Inokuchi K. Role of adult neurogenesis in hippocampal-cortical memory consolidation. Mol Brain 2014;7:13.
63. Koehl M, Abrous DN. A new chapter in the field of memory: Adult hippocampal neurogenesis. Eur J Neurosci 2011;33:1101-14.
64. Kitabatake Y, Sailor KA, Ming GL, Song H. Adult neurogenesis and hippocampal memory function: New cells, more plasticity, new memories? Neurosurg Clin N Am 2007;18:105-13, x.
65. Van der Borght K, Havekes R, Bos T, Eggen BJ, Van der Zee EA. Exercise improves memory acquisition and retrieval in the Y-maze task: Relationship with hippocampal neurogenesis. Behav Neurosci 2007;121:324-34.
66. Kobilo T, Yuan C, van Praag H. Endurance factors improve hippocampal neurogenesis and spatial memory in mice. Learn Mem 2011;18:103-7.
67. Choi JH, Hwang IK, Yi SS, Yoo KS, Lee CH, Shin HC, et al. Effects of streptozotocin-induced type 1 diabetes on cell proliferation and neuronal differentiation in the dentate gyrus; correlation with memory impairment. Korean J Anat 2009;42:41-8.
68. Zhang WJ, Tan YF, Yue JT, Vranic M, Wojtowicz JM. Impairment of hippocampal neurogenesis in streptozotocin-treated diabetic rats. Acta Neurol Scand 2008;117:205-10.
69. Li ZG, Zhang W, Grunberger G, Sima AA. Hippocampal neuronal apoptosis in type 1 diabetes. Brain Res 2002;946:221-31.
70. Ahmadpour S, Sadeghi Y, Sheibanifar M, Haghir H. Neuronal death in dentate gyrus and ca3 in diabetic rats: Effects of insulin and ascorbic acid. Hormozan J Med Sci 2010;13:13-6.
71. Winkler G, Kempler P. Pathomechanism of diabetic neuropathy: Background of the pathogenesis-oriented therapy. Orv Hetil 2010;151:971-81.
72. Vinik AI. Diabetic neuropathy: Pathogenesis and therapy. Am J Med 1999;107:17S-26S.
73. Elmore S. Apoptosis: A review of programmed cell death. Toxicol Pathol 2007;35:495-516.
74. Umanskii SP. Apoptosis: Molecular and cellular mechanisms. Mol Biol (Mosk) 1996;30:487-502.
75. Hung RW, Chow AW. Apoptosis: Molecular mechanisms, regulation and role in pathogenesis. Can J Infect Dis 1997;8:103-9.
76. Topuridze ML, Kipiani VA, Pavliashvili NS, Kipiani NV, Petriashvili TG. Molecular mechanisms of apoptosis. Georgian Med News 2007;150:38-45.
77. Radi E, Formichi P, Battisti C, Federico A. Apoptosis and oxidative stress in neurodegenerative diseases. J Alzheimers Dis 2014;42 Suppl 3:S125-52.
78. Conradt B. Genetic control of programmed cell death during animal development. Annu Rev Genet 2009;43:493-523.
79. Fuchs Y, Steller H. Programmed cell death in animal development and disease. Cell 2011;147:742-58.
80. Yuan J, Horvitz HR. A first insight into the molecular mechanisms of apoptosis. Cell 2004;116 2 Suppl:S53-6.
81. Jakobsen J, Sidenius P, Gundersen HJ, Osterby R. Quantitative changes of cerebral neocortical structure in insulin-treated long-term streptozocininduced diabetes in rats. Diabetes 1987;36:597-601.
82. Garris DR, Diani AR, Smith C, Gerritsen GC. Depopulation of the ventromedial hypothalamic nucleus in the diabetic Chinese hamster. Acta Neuropathol 1982;56:63-6.
83. Verhagen AM, Vaux DL. Molecular mechanisms of apoptosis: An overview. Results Probl Cell Differ 1999;23:11-24.
84. Schwartzman RA, Cidlowski JA. Apoptosis: The biochemistry and molecular biology of programmed cell death. Endocr Rev 1993;14:133-51.
85. Kukhta VK, Marozkina NV, Sokolchik IG, Bogaturova EV. Molecular mechanisms of apoptosis. Ukr Biokhim Zh (1999) 2003;75:5-9.
86. Oyenihi AB, Ayeleso AO, Mukwevho E, Masola B. Antioxidant strategies in the management of diabetic neuropathy. Biomed Res Int 2015;2015:515042.
87. Karunakaran U, Park KG. A systematic review of oxidative stress and safety of antioxidants in diabetes: Focus on islets and their defense. Diabetes Metab J 2013;37:106-12.
88. Maritim AC, Sanders RA, Watkins JB 3rd. Diabetes, oxidative stress, and antioxidants: A review. J Biochem Mol Toxicol 2003;17:24-38.
89. Johansen JS, Harris AK, Rychly DJ, Ergul A. Oxidative stress and the use of antioxidants in diabetes: Linking basic science to clinical practice. Cardiovasc Diabetol 2005;4:5.
90. Sonoda N, Inoguchi T. Role of oxidative stress in pathogenesis of diabetic complications. Nihon Rinsho 2012;70 Suppl 5:231-5.
91. Matough FA, Budin SB, Hamid ZA, Alwahaibi N, Mohamed J. The role of oxidative stress and antioxidants in diabetic complications. Sultan Qaboos Univ Med J 2012;12:5-18.
92. Van Dam PS, Van Asbeck BS, Erkelens DW, Marx JJ, Gispen WH, Bravenboer B. The role of oxidative stress in neuropathy and other diabetic complications. Diabetes Metab Rev 1995;11:181-92.
93. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys 2005;43:289-330.
94. de Oliveira DM, Ferreira Lima RM, El-Bachá RS. Brain rust: Recent discoveries on the role of oxidative stress in neurodegenerative diseases. Nutr Neurosci 2012;15:94-102.
95. Shibata N, Kobayashi M. The role for oxidative stress in neurodegenerative diseases. Brain Nerve 2008;60:157-70.
96. Potashkin JA, Meredith GE. The role of oxidative stress in the dysregulation of gene expression and protein metabolism in neurodegenerative disease. Antioxid Redox Signal 2006;8:144-51.